PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.115 AUD
Market Closed
Updated:
May 29, 2024
PYC Therapeutics Ltd
Net Issuance of Common Stock
|
PYC Therapeutics Ltd
Net Issuance of Common Stock Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Net Issuance of Common Stock
AU$30.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
|
Immutep Ltd
ASX:IMM
|
Net Issuance of Common Stock
AU$80.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
30%
|
CAGR 10-Years
19%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Net Issuance of Common Stock
$83.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Net Issuance of Common Stock
$40.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Net Issuance of Common Stock
AU$6.7m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
30.1m
AUD
30.1m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Net Issuance of Common Stock amounts to 30.1m AUD.
What is PYC Therapeutics Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
17%
17%
The average annual Net Issuance of Common Stock growth rates for PYC Therapeutics Ltd have been -9% over the past three years , 28% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
